The “Community Pharmacy Relief Act,” seeks to address concerns from independent pharmacies over reimbursement rates and business practices that critics say have driven many out of business.
Includes four planned new manufacturing facilities, with ground-breaking today in North Carolina on $2 billion+ facility.
NACDS is highlighting the role of member pharmacies in providing essential health and wellness services.
“Stephanie’s promotion is a testament to her exceptional leadership and to her understanding and advancement of NACDS’ mission,” said NACDS President and CEO Steven C. Anderson.
Nationwide convenings are now underway to advance pharmacy patient care services at scale.
DeWolf, a transformative figure in the industry, received the award, the highest honor in the U.S. consumer healthcare sector, for decades of dedication and service.
New research highlights gaps and barriers for patients to achieve low-density lipoprotein cholesterol (LDL-C) goals and the impact on patient outcomes.
Nourish My Health reaches millions of Americans, particularly in regions with high rates of diet-related diseases.
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.."
AstraZeneca and Andrews introduce SCREEN, a limited-edition t-shirt designed to spark conversation and inspire action on the benefits of early detection.
Accomplished health care executives will work to drive growth, strengthen industry partnerships, and enhance pharmacy innovation at GoodRx.
Report reveals orphans’ growth advantage over non-orphans is narrowing, begging the question - are these drugs still a class apart?
In 2004, Hunter joined NACDS’ meetings and conferences function, and was promoted from manager, to director, to senior director.
